Anorexia and Personality Traits in Elderly Individuals
APETI
1 other identifier
observational
310
1 country
1
Brief Summary
The aim of this study is to evaluate the relationship between age-related anorexia and personality traits in elderly individuals with comorbidities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 2, 2022
CompletedFirst Submitted
Initial submission to the registry
June 9, 2022
CompletedFirst Posted
Study publicly available on registry
June 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2022
CompletedAugust 16, 2022
August 1, 2022
2 months
June 9, 2022
August 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
relationship between anorexia and personality traits
relationship between anorexia and personality traits measured by Simplified Nutritional Appetite Questionnaire (SNAQ) and Five Factor Personality Inventory - Short Form scores
1 week
Eligibility Criteria
65 years of age and older with chronic illness
You may qualify if:
- Being 65 years or older,
- Volunteering to participate in the study,
- Being conscious and not having communication problems,
- Having a Charlson comorbidity index of 1 or higher and/or a diagnosis of hypertension,
- Being fed orally.
You may not qualify if:
- oropharyngeal dysphagia,
- Presence of neurological or muscular disease that prevents swallowing,
- Being fed by nasogastric tube, percutaneous endoscopic gastrostomy or intravenous nutrition,
- Using drugs that affect appetite (corticosteroid, cancer chemotherapy digoxin, opioids, serotonin reuptake inhibitors, topiramate),
- Using appetizers (megestrol acetate, dronabinol, mirtazapine, growth hormone analogue),
- Having an active cancer disease,
- Major neuro-psychiatric disease (Alzheimer's, dementia, major depression, mania, psychosis, etc.),
- Presence of acute infection,
- Not having sufficient communication skills (Mini Mental Test score below 24 points).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sultan Abdülhamid Training and Research Hospital
Üsküdar, Istanbul, 34660, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elif Yıldırım Ayaz, M.D.
Sultan Abdülhamid Training And Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2022
First Posted
June 14, 2022
Study Start
June 2, 2022
Primary Completion
August 1, 2022
Study Completion
August 1, 2022
Last Updated
August 16, 2022
Record last verified: 2022-08